Wednesday, November 25, 2009, 8:36am EST - Canadian Markets open in 54 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Talecris Biotherapeutics Holdings Corp. (TLCR)

On Nov 24: 20.18 USD   0.00 (0.00%)  
MORE ON TLCR
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Talecris Biotherapeutics Holdin (NasdaqNM:TLCR) Delayed quote dataEdit
Last Trade: 20.18 USD
Trade Time: Nov 24
Change: 0.00 (0.00%)
Prev Close: 20.18
Open: N/A
Bid: 19.27 x 100
Ask: 20.88 x 300
1y Target Est: 25.40
Day's Range: N/A - N/A
52wk Range: 18.01 - 23.44
Volume: 0
Avg Vol (3m): 1,382,090
Market Cap: 2.42B
P/E (ttm): 10.68
EPS (ttm): 1.89
Div & Yield: N/A (N/A%)
Talecris Biotherapeutics Holdings Corp. (TLCR)
1d  5d  3m 
 Add TLCR to Portfolio   Download Data

HEADLINES
Biotech Stocks Hot Right Now, Ho-Hum in the Long Run
at The Wall Street Journal Online (Wed, Nov 18)
Talecris to invest $268.7 million in NC plant
AP (Fri, Nov 13)
Talecris to Invest $268.7 Million to Expand its Manufacturing Facility in Clayton
Business Wire (Fri, Nov 13)
There Will Be Blood (Plasma)
at Motley Fool (Wed, Nov 11)
Coverage initiated on Talecris Biotherapeutics by Barclays Capital and Citigroup
Briefing.com (Wed, Nov 11)
Talecris Biotherapeutics Holdings Corp. Earnings Call scheduled for 8:30 am ET today
CCBN (Tue, Nov 10)
TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial
EDGAR Online (Tue, Nov 10)
Talecris Biotherapeutics Announces Third Quarter 2009 Results
Business Wire (Mon, Nov 9)
TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. Files SEC form 10-Q, Quarterly Report
EDGAR Online (Mon, Nov 9)
Q3 2009 Talecris Biotherapeutics Holdings Corp. Earnings Release - After Market Close
CCBN (Mon, Nov 9)
More Headlines for TLCR...

ANALYST
EPS Est (next year) (Dec-09) : 1.36
EPS Est (in 2 years) (Dec-10) : 1.52
Avg Rec (current)*: 2.0
PEG Ratio: 0.99
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Talecris Biotherapeutics Holdings Corp., a biotherapeutic and biopharmaceutical company, engages in the production and marketing of plasma-derived protein therapies worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices